Brend
6.6K posts
Brend
@Bren_JF
I have many reasons to live C:
Mexico Katılım Kasım 2009
1.5K Takip Edilen498 Takipçiler
Brend retweetledi
Great news for #bladdercancer & #globaloncology
@NCCN now provides Framework for Resource Stratification
nccn.org/framework/
Great to be part of international reviewers included in this initiative 🇲🇽🇮🇳 @INCMNSZ_Uronco @TomFlaigMD @SpiessPhilippe @oncodaily @INCMNSZ_DirInv
English
Brend retweetledi
DAY3⃣ @asco #GU26 #kidneycancer The BELZUTIFAN story!
🔴LITESPARK-011 Belzu + lenva vs cabo for aRCC after PDL1
🔵LITESPARK-022 Adjuvant pembro+belzu vs pembro in localized ccRCC @DrChoueiri
🟠LITESPARK-024 dose escalation of belzu + palbo
#ASCOVoices @OncoAlert @oncodaily
English
Brend retweetledi
DAY 1 #prostatecancer news this PM @ASCO #GU26
🛑 PEACE 2: ADT+ RT +/- cabazitaxel in very high-risk localized PCa
📈 P1 escalation studies: VIR-5500 (AMX-500) a dual T-cell engager targeting PSMA & actinium-225-PSMA in mCRPC
🎉 PSMAddition: QOL w Lu-PSMA-617 mHSPC
@OncoAlert
English
Brend retweetledi
Get to know the #ascovoices #GU25 @ASCO @ConquerCancerFd
Follow our experts 📲💻🧑🏼⚕️👨🏻⚕️👩🏻⚕️
They will be summarizing the most important updates in GU Oncology ✅‼️
@OncLive @OncoAlert @UrologyTimes
@bergsa83 @OncBrothers @urotoday @Uromigos @oncodaily @PaolaVS94 @BourlonMaite
English
Brend retweetledi
@incmnszmx we were happy to receive @PBarataMD to discuss about #ProstateCancer 👨🏻⚕️👩🏻⚕️🌍🇲🇽
Multidisciplinary discussion w Urology, Genetics and pathology 📘🖇️🗂️💙
@JoseLuisROli @sof_mb @Elias31222749
English
Brend retweetledi
Estudio que muestra desconexión lo recomendado en el tx oncologico costoso con beneficios marginales y la práctica clínica cotidiana. DOI. 10.1158/1055-9965.EPI-24-0906, participación del @INCMNSZ, Alejandro Aranda Gutiérrez y cols.
Español
Brend retweetledi
Estudio que ilustra la necesidad de realizar pruebas de panel multigénico para la evaluación del riesgo de cáncer genético en mexicanos con con cáncer de páncreas exocrino. Doi: 10.1016/j.pan.2024.09.018, participación del @incmnszmx José Luis Rodríguez Olivares y cols.
Español
Brend retweetledi
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma frontiersin.org/articles/10.33…
English
The best team 💙💯
Maite Bourlon@BourlonMaite
📢 BMS @bmsnews Press release on CheckMate-67T study of subcutaneous Nivolumab while @myESMO begins 🔹P3 trial of SC Nivo vs IV Nivo 🔸Meets co-primary endpoints of Pharmacokinetics 👩🏻🔬 🔹Meets non-inferiority in ORR (secondary endpoint) Great team @AlbigesL @INCMNSZ_Uronco
English